FDA Reviews Popular Peptides BPC-157 and TB-500 Amid RFK Jr. Backing
Health advisers convened by the Food and Drug Administration are reviewing more than a half-dozen peptides, unproven substances that have gained popularity in wellness trends despite limited safety and efficacy data. Kennedy Jr. FDA Panel Weighs Compounding Safety for Popular Peptides Federal regulators are evaluating whether to allow seven popular peptides to be added to … Read more